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ABSTRACT
Objective: To development and validation of a reversed-phase high-performance liquid chromatography (RP-HPLC) for the determination of modafinil 
in bulk and pharmaceutical dosage forms.
Methods: A simple, precise, rapid, and accurate RP-HPLC method was developed for the estimation of modafinil in bulk and pharmaceutical dosage 
forms. Xterra RP 18 (250 mm × 4.6 mm, 5 µ particle size) with a mobile phase consisting of methanol:water 70:30 V/V was used. The flow rate 
1.0 ml/min and the effluents were monitored at 260 nm. The retention time and recovery time was 12 minutes. The detector response was linear in 
the concentration of 10-50 µg/ml. The respective linear regression equation being Y=452.1x+65237. The limit of detection and limit of quantification 
were 4.547 and 1.377 mcg, respectively. The method was validated by determining its accuracy, precision, and system suitability.
Result: The objective of the present work is to develop simple, precise, and reliable HPLC method for the analysis of modafinil in bulk and 
pharmaceutical dosage forms. This is achieved using the most commonly employed Xterra RP 18 (250 mm × 4.6 mm, 5 μ particle size) column 
detection at 260 nm. The present method was validated according to ICH guidelines.
Conclusion: In this study, a simple, fast and reliable HPLC method was developed and validated for the determination of modafinil in pharmaceutical 
formulations.
Keywords: Modafinil, Reversed-phase high-performance liquid chromatography, Estimation, ICH guidelines, Tablets.
INTRODUCTION
Modafinil belongs to the class narcoleptics. The chemical name is 
2-[(Diphenylmethyl)-sulfinyl] acetamide. This is a1-adrenergic agonist. 
Clinical evaluation in hypersomnia and narcolepsy. It is not official in 
any of the pharmacopoeia. It is listed in the Merck Index 13th edition [1] 
and Martindale the complete drug reference 36th edition [2]. Literature 
survey revealed estimation of modafinil by several techniques such as 
simultaneous estimation by high-performance liquid chromatography 
(HPLC) [3], determination of modafinil in human plasma by solid-
phase and liquid-liquid extraction by HPLC [4-6] determination of 
modafinil in human urine by HPLC [7], determination of related 
substance in modafinil [8], and determination of modafinil by a 
chiral chromatography [9] methods have been reported. In this 
study, an attempt was made to develop rapid and economical 
spectrophotometric and reversed-phase HPLC (RP-HPLC) method for 
estimation of modafinil in bulk and pharmaceutical formulation with 





Quantitative HPLC was performed on liquid chromatography, Waters 
separation 2996, photodiode array detector (PDA) detector module 
equipped with automatic injector with injection volume 20 µl, and 2693 
pump. Xterra RP 18 (250 × 4.6 mm, 5 μ particle size was used. The HPLC 
system was equipped with Empower Software.
Chemicals and solvents
Modafinil was provided as gift sample by Orchid Pharma Ltd., Alathur, 
India. The solvents which are used methanol and water of HPLC grade 
were purchased from Merck Specialities Pvt. Ltd., Mumbai, India. 
Commercial tablets of modafinil were purchased from local market. 
HPLC grade water obtained from Milli-Q water purification system was 
used throughout the study [7].
Selection of mobile phase
• Trail 1 - The method is carried out with the mobile phase acetonitrile 
and water in the ratio of 70:30 at the 260 nm. In this method, broad 
peak is found
• Trail 2 - The method is carried out by the mobile phase acetonitrile 
and water in a ratio of 50:50 at 260 nm. In this method, sharp and 
narrow peak is not came, so we change the mobile phase
• Trail 3 - The method was then carried out with the mobile phase 
water and methanol in the ratio of about 90:10 at 260 nm. This 
method does not obey the HPLC parameters
• Trail 4 - The method was then carried out with the mobile phase 
methanol and water in the ratio of about 70:30 at 260 nm. This 
method gives the sharp and narrow peak and it’s obey the HPLC 
parameters, so we select this mobile phase for HPLC.
Preparation of the mobile phase and diluents
The mobile phase is prepared by methanol and water at the ratio of 
70:30 (v/v). The resultant solutions were thoroughly mixed and filtered 
through a poly-tetra-fluoro ethanol filter of 0.45 µm pore size using 
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vacuum pump and degassed by sonication to expel the dissolved gases 
in solvent system.
Preparation of system suitability solution (standard solution)
About 25 mg of modafinil standard powder was weighed and added 
into 25 ml volumetric flask and diluted with methanol to make the 
concentration 100 mcg/ml. 5 ml of this standard stock solution was 
pipette out and transferred into 50 ml volumetric flask and diluted with 
methanol to make the concentration 10 mcg/ml.
Preparation of sample solutions
About 20 tablets were accurately weighed, and the average weight was 
calculated. The tablets are grinded to a fine powder with the help of 
mortar and pestle. Then, the amount of powder equivalent to the average 
weight of a tablet was transferred to a volumetric flask, diluted with 
diluents, and shaken for about 10 minutes then filtered through filter 
paper. The filtered solution was further diluted in the mobile phase to 
make the final concentration of working sample equivalent to 10 mcg/ml.
Chromatographic condition
The samples were introduced by an injector with a 20-μl loop. The 
analysis was performed under isocratic conditions using a flow rate 
1 ml/min at ambient temperature. Chromatograms were recorded at 
λ=260 nm using a detector PDA Shimadzu UV-VIS.
METHODS
The HPLC system was stabilized for 30 minutes by passing mobile phase, 
detector was set at 260 nm, flow rate of 1.0 ml/min to get a stable baseline. 
One blank followed by six replicates of a single standard solution was 
injected to check the system suitability. Six replicates of each standard 
solution 10, 20, 30, 40, and 50 µg/mL were injected. Calibration graph 
was plotted by the concentration of modafinil on X-axis and peak area on 
Y-axis and linearity curve was shown in Fig. 2. The amount of drug present 
in the sample was computed by calibration graph. Chromatographic 
conditions for estimation of modafinil were described in Table 1.
RESULTS AND DISCUSSION
The objective of the present work is to develop simple, precise 
and reliable HPLC method for the analysis of modafinil in bulk 
and pharmaceutical dosage forms. This is achieved using the most 
commonly employed Xterra RP 18 (250 mm × 4.6 mm, 5 μ particle size) 
column detection at 260 nm. The representative chromatogram 
indicating modafinil is shown in Fig. 1.
Parameter fixation
In developing this method, a systemic study of effects of various 
parameters was conducted by varying one parameter at a time and 
controlling all other parameters. The following studies were conducted 
for this purpose.
Stationary phase characteristics
Based on nature and solubility characteristics of RP mode of HPLC was 
selected azithromycin for chromatography. Among different RP-HPLC 
stationary phases tried Xterra RP 18 (250 × 4.6 mm, 5 μ particle size 
was found to be optimum).
Mobile phase characteristics
To get sharp peak with baseline separation from interfering peaks 
carried out a number of experiments by varying the composition 
of solvents and mobile phase flow rate. To have an ideal separation 
of the drug under isocratic conditions, HPLC grade methanol and 
water were used in the ratio of 70:30 (v/v) was proved to be the 
most suitable of all the combinations since the chromatographic 
peak obtained was better defined and resolved and almost free from 
tailing.
Fig. 2: Linearity curve of modafinil
Fig. 1: Typical chromatogram of modafinil
Table 1: Optimized chromatographic conditions of 
modafinil parameters
Parameter Solvents





Injection volume 20 L
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Linearity
A linearity study verifies that the sample solutions are in a concentration 
range where analyte response is linearly proportional to concentration. 
The linearity of response for the present method was determined 
by analyzing standard solution in the concentration range of 10-
50 mcg/ml. The results are showed that the peak areas are linear within 
the concentration of analysis. The correlation coefficient was r2=0.997 
(Fig. 2).
Accuracy
The accuracy of the method was determined by standard addition 
method. A known amount of standard drug was added to the fixed 
amount of pre-analyzed standard solution. The percent recovery and 
% relative standard deviation (%RSD) was calculated, and the results 
are presented in Table 3. Satisfactory recoveries ranging from 97.13%, 
98.73%, 99%, 97.13%, and 97.53% were obtained by the proposed 
method. This indicates that the proposed method was accurate.
Intra-day precision
To study the intra-day precision, three replicate standard solutions 
(300 ppm) of modafinil were injected. The %RSD was calculated and 
it was found to be 0.51 which are well within the acceptable criteria of 
not more than 2.0.
Inter-day precision
To study the inter-day precision, six replicate standard solutions 
(300 ppm) of modafinil were injected. The %RSD was calculated and 
it was found to be 0.42 which are well within the acceptable criteria of 
not more than 2.0.
Specificity
The effect of a wide range of excipients and other additives usually 
present in the formulation of modafinil in the determinations under 
optimum conditions were investigated. Chromatographic parameters 
maintained are specific for modafinil.
Limit of detection (LOD) and limit of quantification (LOQ)
The detection limit of the method was investigated by injecting standard 
solutions of modafinil into the HPLC column. By using the signal-
to-noise method the peak-to-peak noise around the analyte retention 
time is measured, and subsequently, the concentration of the analyte 
that would yield a signal equal to certain value of noise to signal ratio 
is estimated. A signal-to-noise ratio (S/N) of 3 is generally accepted for 
estimating LOD and signal-to-noise ratio of 10 is used for estimating 







Table 3: Recovery analysis of Modafinil








Recovered % SD RSD % SE
Modafinil 1. 15 15 29.57 14.57 97.13
2. 15 15 29.81 14.81 98.73
3. 15 15 29.85 14.85 99 0.89 0.91 0.40
4. 15 15 29.57 14.57 97.13
5. 15 15 29.63 14.63 97.53
SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error
Drug Sample no. Amount present (µg/ml) Amount found (µg/ml) Percentage 
obtained
Average % SD RSD % SE
Modafinil 1. 30 29.57 98.56
2. 30 29.81 99.36 99.14 0.50 0.51 0.29
3. 30 29.85 99.5
SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error
Drug Sample no. Amount present (µg/ml) Amount found (µg/ml) Percentage 
obtained
Mean % SD RSD % SE
Modafinil 1. 30 29.81 99.36
2. 30 29.63 98.76 98.89 0.41 0.42 0.24
3. 30 29.57 98.56
SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error
Drug Sample no. Amount added (µg/ml) Amount present (µg/ml) Percentage 
obtained
Average % SD RSD % SE
Modafinil 1. 30 29.79 99.3
2. 30 29.40 98
3. 30 29.38 97.93  98.45 1.17 1.19 0.52
4. 30 30.01 100
5. 30 29.12 97.06
SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error
Table 2: Linearity results of modafinil
Table 4: Intra-day analysis of modafinil
Table 5: Interday analysis of modafinil
Table 6: Quantification of formulation
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Fig. 3: Different concentration graph, (a) 20 µg/ml, (b) 30 µg/ml, (c) 40 µg/ml, (d) 50 µg/ml
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exhibit baseline noise. The LOD and LOQ for modafinil were found to be 
4.547 and 1.377 µg/ml, respectively.
Robustness
Robustness of the method was determined by making slight changes 
in the chromatographic conditions. It was observed that there were no 
marked changes in the chromatograms, which demonstrated that the 
RP-HPLC method developed is robust.
System suitability
A system suitability test was performed to evaluate the chromatographic 
parameters (number of theoretical plates, tailing of the peak) before 
the validation runs. The analytical method validation was carried out as 
per ICH method validation guidelines.
CONCLUSION
In this study, a simple, fast and reliable HPLC method was developed 
and validated for the determination of modafinil in pharmaceutical 
formulations. As these proposed methods have the lowest LOQ values 
and the wider linear range is a more sensitive method. From the results 
obtained, we concluded that the suggested methods showed high 
sensitivity, accuracy, reproducibility, and specificity. Moreover, these 
methods were simple and inexpensive, and these can be employed for the 
routine quality control of modafinil in pharmaceutical formulations [11].
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